MAPT and Alzheimer disease: This molecule allowed for a selective detection of NFTs of hyperphosphorylated tau proteins in AD brain as it discriminated between NFTs and SPs of Aβ peptides in histological imaging of hippocampus sections from AD patients (Ojida et al., 2009).